Steven K. Libutti, M.D., Surgery Branch and Jacek Capala, Ph.D., Radiation Oncology Branch
Using Tumor Targeting TNF-Gold Nanoparticles to Increase the Efficacy of Radiation Therapy
Tom Misteli, Ph.D., Laboratory of Receptor Biology and Gene Expression
Aging and Tumor Formation
Christoph Rader, Ph.D., Experimental Transplantation and Immunology Branch
Engineering Hybrid Therapeutics
Di Xia, Ph.D., Laboratory of Cell Biology
Monoclonal Antibody-Assisted Selection of P-glycoprotein Conformations for Crystallization
Dalit Barkan, Ph.D., Laboratory of Cancer Biology and Genetics
Discovery of Genes Regulating the Recurrence of Latent Breast Cancer
John A. Beutler, Ph.D., Molecular Targets Development Program
ERAD and UPR as Leverage Points in Myeloma
Chi-Ping Day, Ph.D., Laboratory of Cancer Biology and Genetics
Novel Animal Model for Recurrent Metastatic Disease: New Tools for Therapy Development
Michael G. Espey, Ph.D., Radiation Biology Branch
Modulation of Cancer, Immune and Endothelial Cell Migration by Redox Agents
Jeffrey S. Isenberg, M.D., Laboratory of Pathology
Selective Control of Tissue Blood Flow by Targeting CD47
Amy Jacobs, Ph.D., CCR Nanobiology Program
Targeting of Nanofusion Machines to Cancer Cells
Jonathan L. Jacobs, Ph.D., Laboratory of Receptor Biology and Gene Expression
Molecular Characterization of BRCA1 Autoregulation
Chamelli Jhappan Ph.D., Laboratory of Cancer Biology and Genetics
DNA-Dependent Protein Kinase in Genomic Stability and Oncogenesis
Andrew Jobson, Ph.D., Laboratory of Molecular Pharmacology
Identification of Chk2 as a Potential Lysine-Arginine Kinase
Su Young Kim, M.D., Ph.D., Pediatric Oncology Branch
Targeting the Stroma to Improve Outcome in Osteosarcoma
Christophe Marchand, Ph.D., Laboratory of Molecular Pharmacology
High-throughput Discovery of Tyrosyl-DNA Phosphodiesterase 1 (Tdp1) Inhibitors
Oyindasola Oyelaran, Ph.D., Laboratory of Medicinal Chemistry
Comparative Microarray Profiling of Human Sera to Identify Glycan Cancer Biomarkers
Jung-Eun Park, Ph.D., Laboratory of Metabolism
Development of Peptide-Derived Plk1 Assays in Cancer Tissues
Jason W. Rausch, Ph.D., HIV Drug Resistance Program
Evolving Sequence-Specific Integrases and Methyltransferases
Christophe Redon, Ph.D., and Olga Sedelnikova, Ph.D., Laboratory of Molecular Pharmacology
Histone g-H2AX as a Cancer Biomarker
Rosalba Salcedo, Ph.D., Laboratory of Experimental Immunology
Role of IL-2 and IL-27 in Inhibition of Neuroblastoma Residual Disease
Christina H. Stuelten, Ph.D., Cell and Cancer Biology Branch
Influence of Matrix Elasticity on the Development of Tumor Stem Cells
Binwu Tang, Ph.D., Laboratory of Cell Regulation and Carcinogenesis
Depleting Cancer Stem Cell Populations with Pharmacologic Agents Enhancing TGF-beta Function
Michael Tangrea, Ph.D., Surgery Branch
Direct Label Expression Microdissection (DL-xMD): Novel Method of Labeling Proteins In Situ
William Telford, Ph.D., Experimental Transplantation and Immunology Branch
Multiple Laser Integration in Flow Cytometry Using Fiber Optic Merge Module Technology
Masaki Terabe, Ph.D., Vaccine Branch
Identification of Novel Tumor Lipid Antigens Stimulating Regulatory NKT Cells
Takeshi Tomita, Ph.D., Laboratory of Metabolism
Identification of a Novel UGRP1 Signaling Pathway
Tiffany A. Wallace, Ph.D., Laboratory of Human Carcinogenesis
Differentially Expressed MicroRNAs from Laser Capture Microdissected Prostate Tumors
Yili Yang, Ph.D., Laboratory of Protein Dynamics and Signaling
Identifying Proteins That Are Mutually Regulated by Ubiquitylation and Sumoylation
A service of the National Cancer Institute
